logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 3
  • 1
    Blake, Samuel Charles Rylands
    Born in September 1980
    Individual (2 offsprings)
    Officer
    2023-03-13 ~ now
    OF - Director → CIF 0
  • 2
    Slootweg, Caroline Lindsay
    Born in June 1974
    Individual (5 offsprings)
    Officer
    2023-03-13 ~ now
    OF - Director → CIF 0
  • 3
    3c, Driebergseweg, Ziest, Netherlands
    Corporate (1 offspring)
    Person with significant control
    2023-03-13 ~ now
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
parent relation
Company in focus

KELP BLUE BIOTECH UK LTD

Period: 2023-03-13 ~ now
Company number: 14725984
Registered name
KELP BLUE BIOTECH UK LTD - now
Standard Industrial Classification
03210 - Marine Aquaculture
Brief company account
Average Number of Employees
02024-01-01 ~ 2024-12-31
02023-03-13 ~ 2023-12-31
Fixed Assets - Investments
1,760,928 GBP2024-12-31
201,809 GBP2023-12-31
Debtors
3,390 GBP2024-12-31
10 GBP2023-12-31
Cash at bank and in hand
2,322 GBP2024-12-31
Current Assets
5,712 GBP2024-12-31
10 GBP2023-12-31
Creditors
Current
126,379 GBP2024-12-31
126,605 GBP2023-12-31
Net Current Assets/Liabilities
-120,667 GBP2024-12-31
-126,595 GBP2023-12-31
Total Assets Less Current Liabilities
1,640,261 GBP2024-12-31
75,214 GBP2023-12-31
Equity
Called up share capital
30 GBP2024-12-31
20 GBP2023-12-31
Share premium
1,654,894 GBP2024-12-31
77,594 GBP2023-12-31
Retained earnings (accumulated losses)
-14,663 GBP2024-12-31
-2,400 GBP2023-12-31
Equity
1,640,261 GBP2024-12-31
75,214 GBP2023-12-31
Investments in Group Undertakings
Cost valuation
1,760,928 GBP2024-12-31
201,809 GBP2023-12-31
Additions to investments
1,559,119 GBP2024-12-31
Investments in Group Undertakings
1,760,928 GBP2024-12-31
201,809 GBP2023-12-31
Amounts Owed by Group Undertakings
Current
3,390 GBP2024-12-31
Other Debtors
Current, Amounts falling due within one year
10 GBP2023-12-31
Debtors
Amounts falling due within one year, Current
3,390 GBP2024-12-31
Current, Amounts falling due within one year
10 GBP2023-12-31
Amounts owed to group undertakings
Current
123,979 GBP2024-12-31
124,205 GBP2023-12-31
Other Creditors
Current
2,400 GBP2024-12-31
2,400 GBP2023-12-31

  • KELP BLUE BIOTECH UK LTD
    Info
    Registered number 14725984
    Suite 5 10 Churchill Square, West Malling, Kent ME19 4YU
    PRIVATE LIMITED COMPANY incorporated on 2023-03-13 (3 years 4 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-03-12
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.